Andrew R. Lilja, Campbell W. Strong, Benjamin J. Bailey, K. Thurecht, Z. H. Houston, N. Fletcher, J. McGhee
{"title":"以设计为主导的纳米药物在虚拟现实中的三维可视化","authors":"Andrew R. Lilja, Campbell W. Strong, Benjamin J. Bailey, K. Thurecht, Z. H. Houston, N. Fletcher, J. McGhee","doi":"10.1145/3281505.3281572","DOIUrl":null,"url":null,"abstract":"Nanomedicines are a promising addition to the arsenal of new cancer therapies. During development, scientists must precisely track their distribution in the body, a task that can be severely limited by traditional 2D displays. With its stereoscopic capacity and real-time interactivity, virtual reality (VR) provides an encouraging platform to accurately visualize dynamic 3D volumetric data. In this research, we develop a prototype application to track nanomedicines in VR. This platform has the potential to enhance data assessment, comprehension and communication in preclinical research which may ultimately influence the paradigm of future clinical protocols.","PeriodicalId":138249,"journal":{"name":"Proceedings of the 24th ACM Symposium on Virtual Reality Software and Technology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Design-led 3D visualization of nanomedicines in virtual reality\",\"authors\":\"Andrew R. Lilja, Campbell W. Strong, Benjamin J. Bailey, K. Thurecht, Z. H. Houston, N. Fletcher, J. McGhee\",\"doi\":\"10.1145/3281505.3281572\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nanomedicines are a promising addition to the arsenal of new cancer therapies. During development, scientists must precisely track their distribution in the body, a task that can be severely limited by traditional 2D displays. With its stereoscopic capacity and real-time interactivity, virtual reality (VR) provides an encouraging platform to accurately visualize dynamic 3D volumetric data. In this research, we develop a prototype application to track nanomedicines in VR. This platform has the potential to enhance data assessment, comprehension and communication in preclinical research which may ultimately influence the paradigm of future clinical protocols.\",\"PeriodicalId\":138249,\"journal\":{\"name\":\"Proceedings of the 24th ACM Symposium on Virtual Reality Software and Technology\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the 24th ACM Symposium on Virtual Reality Software and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1145/3281505.3281572\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 24th ACM Symposium on Virtual Reality Software and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1145/3281505.3281572","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Design-led 3D visualization of nanomedicines in virtual reality
Nanomedicines are a promising addition to the arsenal of new cancer therapies. During development, scientists must precisely track their distribution in the body, a task that can be severely limited by traditional 2D displays. With its stereoscopic capacity and real-time interactivity, virtual reality (VR) provides an encouraging platform to accurately visualize dynamic 3D volumetric data. In this research, we develop a prototype application to track nanomedicines in VR. This platform has the potential to enhance data assessment, comprehension and communication in preclinical research which may ultimately influence the paradigm of future clinical protocols.